EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Structure Therapeutics Inc. Sponsored ADR (GPCR) EBITDA Margin data is not available.
| Income Statement Financials | |
-- |
|
$-75.97M |
|
-- |
|
-- |
|
$89.38M |
|
$-89.38M |
|
$13.60M |
|
$-75.78M |
|
$-75.78M |
|
$-75.97M |
|
$-75.97M |
|
$-75.97M |
|
$-75.97M |
|
$-89.38M |
|
$-92.05M |
|
72.44M |
|
72.44M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$1.49B |
|
$6.37M |
|
$17.53M |
|
$1.51B |
|
$56.98M |
|
-- |
|
$4.05M |
|
$61.03M |
|
$1.45B |
|
$1.45B |
|
$1.45B |
|
71.07M |
|
| Cash Flow Statement Financials | |
$15.23M |
|
$-496.95M |
|
$-1.74M |
|
$799.62M |
|
$316.17M |
|
$-483.45M |
|
$11.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$14.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.25% |
|
-5.25% |
|
-5.04% |
|
-5.25% |
|
$20.36 |
|
$0.19 |
|
$0.21 |
|